EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1

Xuemei Bai iD, Ruiqing Ren iD, Jiahua Yuan iD, Liwen Yu iD, Na Dong, Nan Cao, Min Zhou, JiaJia Zhang, Xiaoxiao Li, Ziye He, Bingyu Liu iD, Meng Zhang iD und 1 weitere

Circulation · 2026

DOI: 10.1161/circulationaha.125.076101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2026. Verfasst von Xuemei Bai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Infection, Immunity and Prevention of Shandong Province and Key Laboratory for Experimental Teratology of Ministry of Education, Sh…. Hauptthemen laut MEDLINE: STAT1 Transcription Factor, Protein-Arginine N-Methyltransferases, Myocardial Infarction, Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: During myocardial infarction (MI), M1-like macrophages exacerbate myocardial injury by excessively secreting inflammatory cytokines. Therefore, modulating the activity of M1-like macrophages may represent a novel therapeutic strategy for MI. PRMTs (protein arginine methyltransferases) primarily regulate protein function via asymmetric dimethylation, but PRMT9 does so through symmetric dimethylation. However, its role in cardiovascular diseases has yet to be established. In this study, we investigated the role of PRMT9 in macrophage polarization in the context of MI and explored its therapeutic effect for MI. METHODS: The correlation between PRMT9 in monocytes/macrophages and MI was investigated using the MI dataset GSE166780. Peripheral blood mononuclear cells were obtained from healthy individuals and patients with MI and analyzed to assess PRMT9 expression. We elucidated the functional role of PRMT9 in MI using macrophage-specific Prmt9 knockout mice and macrophage-specific overexpression adeno-associated virus vectors. We explored the underlying mechanisms through flow cytometry, transcriptome analysis, immunoprecipitation/mass spectrometry analysis, and functional experiments. RESULTS: We discovered that PRMT9 was highly expressed in murine and human peripheral blood mononuclear cells in the early stages of MI. PRMT9 deficiency enhanced M1-like polarization and exacerbated cardiac damage in murine models of MI. Conversely, PRMT9 overexpression in macrophages reduced infarct size, accelerated inflammation resolution, and improved cardiac function after MI. Our findings established that PRMT9-catalyzed methylation played an important role in STAT1 (signal transducer and activator of transcription 1)–mediated macrophage polarization. Mechanistically, PRMT9 directly binds to STAT1 and facilitates its symmetric dimethylation at R588 and R736. Further analysis revealed that PRMT9-mediated symmetric dimethylation facilitated STAT1 ubiquitination, which promoted STAT1 recognition by SQSTM1/p62 (sequestosome-1) and NDP52/CALCOCO2 (nuclear dot protein 52), facilitating STAT1-selective autophagic degradation and suppressing excessive M1-like macrophage responses. Moreover, we demonstrated that the STAT1 inhibitor fludarabine, a clinically used chemotherapeutic agent, mitigated the exacerbation of post-MI myocardial injury induced by PRMT9 deletion in macrophages. CONCLUSIONS: This study discovered a novel PRMT9-driven symmetric dimethylation of STAT1, resulting in its ubiquitination and lysosomal degradation, which suppresses the proinflammatory polarization of macrophages and mitigates myocardial damage following MI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT1 Transcription FactorProtein-Arginine N-MethyltransferasesMyocardial InfarctionMacrophagesAnimalsHumansMiceMice, KnockoutMethylationMaleMice, Inbred C57BL

Stichwörter der Autor:innen

M1-like macrophageMyocardial infarctionPRMT9STAT1methylation

Substanzen

STAT1 Transcription FactorProtein-Arginine N-MethyltransferasesSTAT1 protein, humanStat1 protein, mouse

Autor:innen und Institutionen

  • Key Laboratory of Infection, Immunity and Prevention of Shandong Province and Key Laboratory for Experimental Teratology of Ministry of Education, Shandong University, Jinan, Shandong 250012, P.R. China (X.B., J.Y., N.D…
  • Department of Immunology, Shandong University, Jinan, Shandong 250012, P.R. China (X.B., J.Y., N.D., N.C., M. Zhou, J.Z., X.L., Z.H., B.L., C.G.).
  • State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province; Department of Cardiology, Qilu Hospita…

ORCID-Profile: Xuemei Bai, Ruiqing Ren, Jiahua Yuan, Liwen Yu, Bingyu Liu, Meng Zhang

Zitieren

APA

Bai, X., Ren, R., Yuan, J., Yu, L., Dong, N., Cao, N., Zhou, M., Zhang, J., Li, X., He, Z., Liu, B., Zhang, M., & Gao, C. (2026). Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1. Circulation. https://doi.org/10.1161/circulationaha.125.076101

Vancouver

Bai X, Ren R, Yuan J, Yu L, Dong N, Cao N, et al. Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1. Circulation. 2026. doi:10.1161/circulationaha.125.076101

BibTeX
@article{Bai2026,
  author = {Bai, Xuemei and Ren, Ruiqing and Yuan, Jiahua and Yu, Liwen and Dong, Na and Cao, Nan and Zhou, Min and Zhang, JiaJia and Li, Xiaoxiao and He, Ziye and Liu, Bingyu and Zhang, Meng and Gao, Chengjiang},
  title = {Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.125.076101}
}
Kostenlos starten →